Medications and DrugsBrand Names: XgevaGeneric Name: denosumab (Xgeva) (Pronunciation: den OH sue mab)
What is denosumab (Xgeva) (Xgeva)?Denosumab is a monoclonal antibody. Monoclonal antibodies are made to target and destroy only certain cells in the body. This may help to protect healthy cells from damage. The Xgeva brand of denosumab is used to prevent bone fractures and other skeletal conditions in people with tumors that have spread to the bone. Xgeva is not for use in people with multiple myeloma (bone marrow cancer). This medication guide provides information about the Xgeva brand of denosumab. Prolia is another brand of denosumab used to treat osteoporosis in postmenopausal women who have high risk of bone fracture. Denosumab may also be used for purposes not listed in this medication guide. What are the possible side effects of Xgeva (Xgeva)?Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Call your doctor at once if you have a serious side effect such as:
Less serious side effects may include: This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. What is the most important information I should know about Xgeva (Xgeva)?This medication guide provides information about the Xgeva brand of denosumab. Prolia is another brand of denosumab used to treat osteoporosis in postmenopausal women who have high risk of bone fracture. You should not receive denosumab if you are allergic to it, or if you have low levels of calcium in your blood (hypocalcemia). Before you receive this medication, tell your doctor if you have kidney disease or if you are on dialysis. Some people using denosumab have developed bone loss in the jaw, also called osteonecrosis of the jaw. Symptoms may include jaw pain, swelling, numbness, loose teeth, gum infection, or slow healing after injury or surgery involving the gums. You may be more likely to develop osteonecrosis of the jaw if you have cancer or have been treated with chemotherapy, radiation, or steroids. Other conditions associated with osteonecrosis of the jaw include blood clotting disorders, anemia (low red blood cells), and a pre-existing dental problem. If you need to have any dental work (especially surgery), tell the dentist ahead of time that you are receiving denosumab. You may need to stop using the medicine for a short time. (Page 1 of 3) Report Problems to the Food and Drug Administration You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088. Need help identifying pills and medications? |
Cancer
Get the latest treatment options.
From WebMD
Cancer Resources
Featured Centers
Health Solutions From Our Sponsors
Featured Topics
Most Popular Topics
Medical Dictionary
Pill Identifier on RxList
- quick, easy,
pill identification
Find a Local Pharmacy
- including 24 hour, pharmacies

